The lab of Lorraine Gudas, Ph.D., has identified a gene that may provide a new, super specific target for drugs that could stop kidney cancer progression in its tracks. Read more
Senior Scientific, LLC, has established a research collaboration with Weill Cornell Medicine to investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers. Read more
Dean Laurie Glimcher pens a guest piece about the role academic medical centers will have in realizing Vice President Joe Biden's "moonshot to cure cancer" campaign. Read more
A team of researchers led by Himisha Beltran, M.D., discovered the genetic, epigenetic and molecular features that underlie neuroendocrine prostate cancer. Read more